Substance / Medication

Terbinafine hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Efficacy and safety of terbinafine hydrochloride spray and 3% boric acid alcohol ear drops in otomycosis.
Xu Shuai, Li Jianfeng, Ding Ling et al. · Acta Otolaryngol · 2020
PMID: 32022618RCT
Development of topical hydrogels of terbinafine hydrochloride and evaluation of their antifungal activity.
Çelebi Nevin, Ermiş Seda, Özkan Semiha · Drug Dev Ind Pharm · 2015
PMID: 24576265Observational
Onychopharmacokinetics of terbinafine hydrochloride penetration from a novel topical formulation into the human nail in vitro.
Hui Xiaoying, Lindahl Åke, Lamel Sonia et al. · Drug Dev Ind Pharm · 2013
PMID: 22873754Observational
In vitro-in vivo correlation study for the dermatopharmacokinetics of terbinafine hydrochloride topical cream.
Saeheng Suwadee, Nosoongnoen Wichit, Varothai Supenya et al. · Drug Dev Ind Pharm · 2013
PMID: 23057672Observational
Ethosomes, binary ethosomes and transfersomes of terbinafine hydrochloride: a comparative study.
Zhang Jian-Ping, Wei Yu-Hui, Zhou Yan et al. · Arch Pharm Res · 2012
PMID: 22297749Observational
Determination of terbinafine hydrochloride in cat hair by two chromatographic methods.
Kuzner J, Kozuh Erzen N, Drobnic-Kosorok M · Biomed Chromatogr · 2001
PMID: 11748682Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Terbinafine hydrochloride (substance)
SNOMED CT
108927002
UMLS CUI
C0771029

Clinical Data

This intervention maps to 6 entities in the Healos knowledge graph.

6
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.